Company Overview and News
The Dow enjoyed a week of strong gains, shrugging off the gloom of the last two weeks. President Trump’s decision to exit the Iran deal weighed on investor sentiment. However, this development also boosted oil prices, leading to a rally for energy stocks. Tech stocks continued to register strong performances while economic data remained encouraging.
The government has become anxious after receiving classified documents containing information about recent defence contracts, and an anonymous letter alleging corruption, the Economic Times reported.
LONDON — President Donald Trump's decision to pull out of the Iran nuclear deal has left foreign firms with a choice: Stop doing business in Iran or run the risk of U.S. sanctions.
In this photo, taken Oct. 11, 2014, an Iranian worker assembles a Peugeot 206 at the state-run Iran-Khodro automobile manufacturing plant near Tehran, Iran. From brand-new airplanes to oilfields, billions of dollars of deals stand on the line for international corporations as President Donald Trump weighs whether to pull America out of Iran’s nuclear deal with world powers. (Photo by EBRAHIM NOROOZI / AP)
WASHINGTON (AP) — Major companies, particularly in Europe, could see billions of dollars in commercial deals canceled because of the U.S. decision to reinstall sanctions on Iran, though the ultimate impact remains unclear due to the possibility of renegotiations and exemptions, experts say.
The U.S. withdrawal from the Iran nuclear deal means Boeing's licenses to sell billions of dollars in commercial jetliners to Iran will be revoked, Treasury Secretary Steven Mnuchin said Tuesday.
DUBAI, UNITED ARAB EMIRATES – From airplanes to oilfields, billions of dollars are on the line for international corporations as President Donald Trump weighs whether to pull America out of Iran’s nuclear deal with world powers.
From airplanes to oilfields, billions of dollars are on the line for international corporations as President Donald Trump weighs whether to pull America out of Iran's nuclear deal with world powers. Regardless of where they are headquartered, virtually all multinational corporations do business or banking in the U.S., meaning any return to pre-deal sanctions could torpedo deals made after the 2015 agreement came into force.
In this photo, taken Jan. 12, 2017, the pilot of Iran Air’s new Airbus plane waves a national flag after landing at Mehrabad International Airport in Tehran, Iran. From brand-new airplanes to oilfields, billions of dollars of deals stand on the line for international corporations as President Donald Trump weighs whether to pull America out of Iran’s nuclear deal with world powers. (Photo by VAHID SALEMI / AP)
DUBAI, United Arab Emirates (AP) — From airplanes to oilfields, billions of dollars are on the line for international corporations as President Donald Trump weighs whether to pull America out of Iran's nuclear deal with world powers.
Airbus Group released its first quarter financial report on 27 April showing an annual decline in sales for the period, across the business and in Airbus Defence and Space.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Will it or won’t it? Will Boeing Co (NYSE:BA) shrug off a trade war, if indeed one is brewing? Or, are owners of Boeing stock simply fretting for no good reason?
The German unit of European missiles maker MBDA and U.S. arms company Lockheed Martin Corp have formed a joint venture to press ahead with a new air and missile defense system being negotiated with the German military, they said on Thursday.
BERLIN (Reuters) - The German unit of European missiles maker MBDA and U.S. arms company Lockheed Martin Corp (LMT.N) have formed a joint venture to press ahead with a new air and missile defense system being negotiated with the German military, they said on Thursday.
8h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
8h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
18h - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...